To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
Clinical trial NCT06840496 · RECRUITING
Trial details
- NCT number
- NCT06840496
- Sponsor
- Biomed Industries, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-30
- Primary completion
- 2027-09-30
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.